West Pharmaceutical Services Inc (WST)
Fixed asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 2,893,100 | 2,876,300 | 2,876,800 | 2,928,600 | 2,949,800 | 2,926,500 | 2,866,000 | 2,883,500 | 2,886,900 | 2,909,000 | 2,928,600 | 2,880,900 | 2,831,600 | 2,681,000 | 2,522,500 | 2,326,100 | 2,146,900 | 2,037,300 | 1,945,400 | 1,887,900 |
| Property, plant and equipment | US$ in thousands | — | — | — | — | — | 1,408,400 | 1,261,300 | 1,215,200 | 1,158,300 | 1,069,000 | 1,077,400 | 1,065,900 | 1,057,500 | 1,065,000 | 1,035,900 | 930,800 | 943,200 | 883,400 | 839,800 | 828,300 |
| Fixed asset turnover | — | — | — | — | — | 2.08 | 2.27 | 2.37 | 2.49 | 2.72 | 2.72 | 2.70 | 2.68 | 2.52 | 2.44 | 2.50 | 2.28 | 2.31 | 2.32 | 2.28 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $2,893,100K ÷ $—K
= —
The fixed asset turnover ratio for West Pharmaceutical Services Inc has exhibited fluctuating trends over the reported periods. From March 31, 2020, to March 31, 2022, the ratio increased steadily from 2.28 to 2.70, indicating that the company was generating more revenue relative to its investment in fixed assets during this period.
However, during the subsequent quarters from June 30, 2022, to September 30, 2023, the fixed asset turnover ratio remained relatively stable at around 2.70 before declining to 2.08 by September 30, 2023. This decrease in the ratio suggests that the company's ability to generate revenue from its fixed assets weakened.
The data shows missing values for the fixed asset turnover ratio from December 31, 2023, to December 31, 2024, which could indicate a lack of specific financial information for those periods or changes in the company's reporting practices.
Overall, analyzing the fixed asset turnover ratio of West Pharmaceutical Services Inc reveals a mix of positive and concerning trends in terms of how efficiently the company is utilizing its fixed assets to generate revenue.
Peer comparison
Dec 31, 2024